Europe – New features further strengthen Priority Medicines scheme (PRIME)

EMA is introducing a number of new features to the PRIority Medicines (PRIME) scheme to strengthen its support for the development of medicines in areas of...

Europe – EU recommendations for 2023-2024 seasonal flu vaccine composition

EMA has issued the recommendations for the influenza virus strains that vaccine manufacturers should include in vaccines for the prevention of seasonal influenza from...

Europe – EMA recommends approval of Bimervax as a COVID-19 booster vaccine

EMA’s human medicines committee (CHMP) has recommended authorising the COVID-19 vaccine Bimervax (previously COVID-19 Vaccine HIPRA) as a booster in people aged 16 years...

UK – AstraZeneca and Amgen’s Tezspire recommended by NICE for severe asthma

The final draft guidance from the National Institute for Health and Care Excellence (NICE) specifically applies to patients who are inadequately controlled with high...

NOS PROCHAINES FORMATIONS